Week 1 Pharm Made Easy Analysis and ATI Report.docx NR 293 Nitrofurantoin (Macrobid): Treatment for Lower Urinary Tract Infections Chamberlain College of Nursing NR 293 – Pharmacology Nitrofurantoin is a medica
...
Week 1 Pharm Made Easy Analysis and ATI Report.docx NR 293 Nitrofurantoin (Macrobid): Treatment for Lower Urinary Tract Infections Chamberlain College of Nursing NR 293 – Pharmacology Nitrofurantoin is a medication that is only available by mouth but can is found as a capsule, extended-release capsule, and an oral suspension. Some common brand names for Nitrofurantoin are; Furadantin, Macrodantin, and the most used is Macrobid (Vallerand & Sanoski, 2017). Nitrofurantoin (Macrobid) is classified as an anti-infective and is used to treat urinary tract infections. These urinary tract infections can be gram-negative or gram-positive. Nitrofurantoin can treat most gram-negative bacteria and some gram-positive bacteria, which include Staphylococcus aureus, staphylococcus epidermis, and Enterococcus (Vallerand & Sanoski, 2017). The administration of Nitrofurantoin includes knowing that tablets cannot be crushed, and capsules cannot be opened, this affects the effectiveness of the medication and the absorption. Another thing to keep in mind during administration is that when giving an oral suspension, it is important to shake it well to help distribute the medication equally in the solution (Vallerand & Sanoski, 2017). Upon giving an oral dose, make sure the patient takes it with food or milk as this helps with gastrointestinal irritation. As a nurse, it is essential to educate our patients on taking medication as directed, be sure to inform the patient that this medication should be taken for a minimum of 7 days and for a. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .. .. . . . . . . . . . . . . . . . . . .. . . . .
[Show More]